![Terrie Curran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Terrie Curran
Direktör/Styrelseledamot på
ARCUTIS BIOTHERAPEUTICS, INC.
Förmögenhet: 4 M $ per 2026-07-31
Profil
Ms. Terrie Curran is an Independent Director at Arcutis Biotherapeutics, Inc. She is on the Board of Directors at Arcutis Biotherapeutics, Inc. and Roivant Sciences, Inc. Ms. Curran was previously employed as a President, Chief Executive Officer & Director by Phathom Pharmaceuticals, Inc., an Independent Director by Myovant Sciences Ltd., an Independent Director by H.
Lundbeck A/S, a President-Global Inflammation & Immunology by Celgene Corp., a SVP & GM-Global Women's Health by Merck & Co., Inc., and a General Manager by Schering-Plough Corp.
She also served on the board at BioNJ, Inc. She received her undergraduate degree from the University of Technology Sydney.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-23 | 389 860 ( 0,49 % ) | 3 M $ | 2026-07-31 | |
| 2026-06-05 | 17 748 ( 0,01 % ) | 476 711 $ | 2026-07-31 |
Aktiva positioner av Terrie Curran
| Företag | Position | Start |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Direktör/Styrelseledamot | 2020-11-02 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Terrie Curran
| Företag | Position | Slut |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Verkställande Direktör | 2025-03-31 |
| MYOVANT SCIENCES LTD. | Direktör/Styrelseledamot | 2023-03-10 |
| CELGENE | Företagsledare/Principal | 2019-09-01 |
| H. LUNDBECK A/S | Direktör/Styrelseledamot | 2017-03-01 |
| MERCK & CO., INC. | Företagsledare/Principal | 2013-04-01 |
Terrie Currans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
78
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
University of Technology Sydney
 University of Technology Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders | Health Technology |
